The four most common diseases in Chile

Radio TXS interview

Science has its rockstars and they will be on TXSRadio.com.
Gabriel León interviews Dr. Hernán González, to talk about thyroid cancer and how to avoid unnecessary surgeries.

Australian scientist warns at BMRC Consortium seminar about super bacteria that threatens a third of humanity

Australian scientist warns at BMRC Consortium seminar about super bacteria that threatens a third of humanity

In the event organized by the Biomedical Research Consortium-Chile, an entity formed by UC and Abbott, Dr. Dane Parker of the University of Rutgers (United States) explained that golden staphylococcus is among the five microorganisms most resistant to antibiotics and raises risks in terms of hospital infections and occurrence of sepsis in Chile.

Consortium in Clinical-Molecular Biomedicine held seminar

Consortium in Clinical-Molecular Biomedicine held seminar

Annual contingency in health due to respiratory infections: vaccines and diagnostic methods

INTERNATIONAL RESEARCH EXHIBITED IN CHILE HOLDS THAT A SUPER BACTERIA THREATENS A HUMANITY TRADE

INTERNATIONAL RESEARCH EXHIBITED IN CHILE HOLDS THAT A SUPER BACTERIA THREATENS A HUMANITY TRADE

Patents Map

All Patents

View patents

Patents Applied for

View patents

Patents Granted

View patents

Dr. Alexis Kalergis

"Human Metapneumovirus causes high morbidity in the population, especially in infants and the elderly." The severity of this virus is the second cause of childhood pneumonia. Our team has developed a safe and effective vaccine against this virus. This has shown excellent protection results in pre-clinical studies.We are currently carrying out the clinical studies necessary to bring this vaccine onto the market and reduce the impact of this disease in the Chilean and international population."

Research Line / Vaccines
Project:
Safe and effective vaccines against Human Metapneumovirus (hMPV)

Dra. Susan Bueno

"Diagnostic tests only detect viruses, they do not detect bacteria, nor do they report on the severity of inflammatory response and the severity of infection. All of this along with the high costs of current testing creates the challenge and opportunity to develop one test that detects the multiple infectious agents in the respiratory tract in a specific, sensitive and simultaneous way and that detects some gravity and prognosis parameters of the patient so the doctor may decide on the best treatment option.”

Research / Diagnostic Line
Project:
Immunological Tools to Detect Respiratory Pathogens

Dr. Carlos Fardella

"The development of this project has allowed us to generate a multidisciplinary knowledge platform in order to collaborate in solving the problem of the increasing incidence of metabolic diseases in our population and at a global level."

Research / Therapy Line
Project:
Development of new drugs for the treatment of hypertension and metabolic syndrome

Dr. Hernán González

"Globally, there are 600,000 cases of thyroid cancer annually. However, there is not one test to predict the aggressiveness of this illness in order to choose more precise treatments according to the patient's profile. After the development of a thyroid cancer diagnostic test - known as Thyrioprint - it was logical to follow up with a second test that could predict with high accuracy the biological behavior of the tumor. Knowing how aggressive the cancer is can change the definitive treatment of the profile of the patient prior to surgery.”

Research Line / Diagnostics
Project:
Thyroid Cancer Prognosis Test

Av. Libertador Bernardo O'Higgins 440, piso 12, Santiago, chile.

Phone: (56) 223541958 / Email: info@bmrc.cl